Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Vanasse A"'
Autor:
Sékou Samadoulougou, Leanne Idzerda, Roxane Dault, Alexandre Lebel, Anne‐Marie Cloutier, Alain Vanasse
Publikováno v:
Obesity Science & Practice, Vol 6, Iss 6, Pp 677-693 (2020)
Summary Background Health care administrative databases are increasingly used for health studies and public health surveillance. Cases of individuals with obesity are selected using case‐identification methods. However, the validity of these method
Externí odkaz:
https://doaj.org/article/ad6b75e5ecb44280a4207c4f67578e5b
Publikováno v:
Canadian Journal of Respiratory, Critical Care, and Sleep Medicine. 6:237-247
Autor:
Shaji Kumar, Carl Simon, Andreas Guenther, Fang Xiang, Sylvia Zhao, K. Gary Vanasse, Enrique M. Ocio, Yeow Tee Goh, Nicolas Hohmann, Sheeba K. Thomas, Marc S. Raab, Moshe Talpaz
Publikováno v:
Leukemia. 33:2924-2933
PIM447, a novel pan-PIM inhibitor, has shown preclinical activity in multiple myeloma (MM). In the multicenter, open-label, first-in-human study, patients with relapsed and/or refractory MM were enrolled to determine the maximum-tolerated dose (MTD)
Autor:
Simon Couillard, Maryse Bélanger, Thomas G. Poder, Pierre Larivée, Alain Vanasse, Qing Li, Nathalie Carrier, Josiane Courteau
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 14:331-341
Purpose The impacts of high blood eosinophil count (HBEC) at admission for COPD exacerbation on posthospitalization outcomes are still unclear. Previous studies have focused on its associations with first readmission rates; yet, its impacts on longit
Autor:
Shira E. Eisman, Ross L. Levine, Wenbin An, Bing Li, Benjamin H. Durham, Maria Pinzon-Ortiz, Barbara Spitzer, Aishwarya Krishnan, Shoron Mowla, Andriy Derkach, Gary J. Vanasse, Xianhui Rong, Raajit K. Rampal, Sean M. Devlin, Justin T. Whitfield, Keith B. Cordner, Tyler Longmire, Amritha Varshini Hanasoge Somasundara, Zhu A Cao, Richard Koche
Publikováno v:
Clin Cancer Res
Purpose: The JAK1/2 inhibitor ruxolitinib has demonstrated significant benefits for patients with myeloproliferative neoplasms (MPN). However, patients often lose response to ruxolitinib or suffer disease progression despite therapy with ruxolitinib.
Autor:
Pellegrini, Cristina, Botta, Francesca, Massi, Daniela, Martorelli, Claudia, Facchetti, Fabio, Gandini, Sara, Maisonneuve, Patrick, Avril, Marie-Françoise, Demenais, Florence, Bressac-de Paillerets, Brigitte, Hoiom, Veronica, Cust, Anne E, Anton-Culver, Hoda, Gruber, Stephen B, Gallagher, Richard P, Marrett, Loraine, Zanetti, Roberto, Dwyer, Terence, Thomas, Nancy E, Begg, Colin B, Berwick, Marianne, Puig, Susana, Potrony, Miriam, Nagore, Eduardo, Ghiorzo, Paola, Menin, Chiara, Manganoni, Ausilia Maria, Rodolfo, Monica, Brugnara, Sonia, Passoni, Emanuela, Sekulovic, Lidija Kandolf, Baldini, Federica, Guida, Gabriella, Stratigos, Alexandros, Ozdemir, Fezal, Ayala, Fabrizio, Fernandez-de-Misa, Ricardo, Quaglino, Pietro, Ribas, Gloria, Romanini, Antonella, Migliano, Emilia, Stanganelli, Ignazio, Kanetsky, Peter A, Pizzichetta, Maria Antonietta, García-Borrón, Jose Carlos, Nan, Hongmei, Landi, Maria Teresa, Little, Julian, Newton-Bishop, Julia, Sera, Francesco, Fargnoli, Maria Concetta, Raimondi, Sara, Alaibac, Mauro, Ferrari, Andrea, Valeri, Barbara, Sicher, Mariacristina, Mangiola, Daniela, Nazzaro, Gianluca, Tosti, Giulio, Mazzarol, Giovanni, Giudice, Giuseppe, Ribero, Simone, Astrua, Chiara, Mazzoni, Laura, Orlow, Irene, Mujumdar, Urvi, Hummer, Amanda, Busam, Klaus, Roy, Pampa, Canchola, Rebecca, Clas, Brian, Cotignola, Javiar, Monroe, Yvette, Armstrong, Bruce, Kricker, Anne, Litchfield, Melisa, Tucker, Paul, Stephens, Nicola, Switzer, Teresa, Theis, Beth, From, Lynn, Chowdhury, Noori, Vanasse, Louise, Purdue, Mark, Northrup, David, Rosso, Stefano, Sacerdote, Carlotta, Leighton, Nancy, Gildea, Maureen, Bonner, Joe, Jeter, Joanne, Klotz, Judith, Wilcox, Homer, Weiss, Helen, Millikan, Robert, Mattingly, Dianne, Player, Jon, Tse, Chiu-Kit, Rebbeck, Timothy, Walker, Amy, Panossian, Saarene, Setlow, Richard, Mohrenweiser, Harvey, Autier, Philippe, Han, Jiali, Caini, Saverio, Hofman, Albert, Kayser, Manfred, Liu, Fan, Nijsten, Tamar, Uitterlinden, Andre G., Kumar, Rajiv, Bishop, Tim, Elliott, Faye, Lazovich, Deann, Polsky, David, Hansson, Johan, Pastorino, Lorenza, Gruis, Nelleke A., Bouwes Bavinck, Jan Nico, Aguilera, Paula, Badenas, Celia, Carrera, Cristina, Gimenez-Xavier, Pol, Malvehy, Josep, Puig-Butille, Joan Anton, Tell-Marti, Gemma, Blizzard, Leigh, Cochrane, Jennifer, Branicki, Wojciech, Debniak, Tadeusz, Morling, Niels, Johansen, Peter, Mayne, Susan, Bale, Allen, Cartmel, Brenda, Ferrucci, Leah, Pfeiffer, Ruth, Palmieri, Giuseppe, Kypreou, Katerina, Bowcock, Anne, Cornelius, Lynn, Council, M. Laurin, Motokawa, Tomonori, Anno, Sumiko, Helsing, Per, Andresen, Per Arne, Guida, Stefania, Wong, Collaborators (98): Alaibac M, Terence H., Ferrari, A, Valeri, B, Et, Al.
Publikováno v:
Lancet Child & Adolescent Health
LANCET CHILD & ADOLESCENT HEALTH
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Lancet Child & Adolescent Health, 3(5), 332-342. Elsevier
The Lancet. Child & adolescent health, vol 3, iss 5
Lancet Child Adolesc Health
LANCET CHILD & ADOLESCENT HEALTH
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Lancet Child & Adolescent Health, 3(5), 332-342. Elsevier
The Lancet. Child & adolescent health, vol 3, iss 5
Lancet Child Adolesc Health
Ferrari, Andrea/0000-0002-4724-0517; Pellegrini, Cristina/0000-0003-2168-8097; Migliano, Emilia/0000-0002-5316-8937; Maisonneuve, Patrick/0000-0002-5309-4704; Guida, Stefania/0000-0002-8221-6694; Pastorino, Lorenza/0000-0002-2575-8331; CARRERA, CRIST
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4be7fb7756edb069e5b275b25e38ef3c
https://researchonline.lshtm.ac.uk/id/eprint/4652504/1/Sera_etal_2019_mc1r_variants_childhood_adolescent_melanoma.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4652504/1/Sera_etal_2019_mc1r_variants_childhood_adolescent_melanoma.pdf
BackgroundRecent studies suggest that hydroxychloroquine (HCQ) could be effective against COVID-19. It is reasonable to expect that if HCQ can prevent or reduce the adverse effects of influenza, it may also reduce the effects of COVID-19 in humans. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e35ac66e925fbc4f9518e9befeca7f0
https://doi.org/10.1101/2020.04.08.20057893
https://doi.org/10.1101/2020.04.08.20057893
Autor:
Lucie Blais, Marie-France Beauchesne, Sylvie Perrault, Paul Farand, Alain Vanasse, Geneviève Letemplier, Roxanne Dault
Publikováno v:
Canadian Journal of General Internal Medicine. 13:6-14
Background: Data on treatment expectation and perception towards vitamin K antagonists (VKAs), direct oral anticoagulants (DOACs), and low molecular weight heparins (LMWH) for the management of venous thromboembolism (VTE) are sparse.Methods: Prospec
Autor:
Jeremy Hatem Tchaicha, S. Subramanian, Michelle Ols, S. Lajoie, J. ter Meulen, G. Vanasse, M. Khattar, Sethi Dhruv Kam, F. Nabulsi, S. Tam, D. Thornton, G. Wilmes, A.V. Ocando, C. Vallaster, J. Tremblay, Rachel A. Burga, Colleen Foley, Gabriel Helmlinger, K. Pedro, S. Saha
Publikováno v:
Annals of Oncology. 32:S852
Autor:
Constance M. Yuan, Hao-Wei Wang, Steven A. Rosenberg, David F. Stroncek, Stephanie L. Goff, Steven L. Highfill, Maryalice Stetler-Stevenson, James Chih-Hsin Yang, Elisabet E. Manasanch, Jennifer N. Brudno, Lekha Mikkilineni, Vicki Fellowes, Rashmika Patel, Danielle Vanasse, Richard M. Sherry, Jennifer Mann, James N. Kochenderfer, Micaela Ganadan, Norris Lam, Irina Maric
Publikováno v:
Blood. 136:50-51
T cells expressing chimeric antigen receptors (CAR) that target B-cell maturation antigen (BCMA) recognize and eliminate multiple myeloma (MM). BCMA is expressed by nearly all cases of MM. BCMA has a restricted expression pattern on normal cells. To